User Acceptance Testing List

Standard Operating Procedure: User Acceptance Testing (UAT) Lifecycle Management

Document ID: SOP-OPS-UAT-042
Classification: Enterprise Operational Standard

---

1. Document Control & Revision History

---

2. Executive Summary & Scope

2.1 Purpose

This Standard Operating Procedure (SOP) defines the mandatory governance, operational workflows, and verification protocols for User Acceptance Testing (UAT) across all enterprise software, hardware, and workflow deployments. It ensures that solutions meet business requirements, operate within designated risk tolerances, and achieve formal stakeholder sign-off prior to production promotion.

2.2 Operational Boundaries

This procedure applies to all internal departments, external vendors, system integrators, and project teams delivering modifications, upgrades, or greenfield implementations affecting enterprise operational ecosystems.

2.3 Regulatory & Compliance Standards

Operations governed by this SOP must comply with:

• ISO/IEC/IEEE 29119-4: Software engineering — Software testing — Test techniques.
• SOX (Sarbanes-Oxley Act): Financial system data integrity and access control validations.
• HIPAA/GDPR: Personally Identifiable Information (PII) masking and data protection compliance during testing phases.

---

3. Prerequisites & Tool Requirements

Execution of this SOP requires specific technical environments, role-based access controls, and validation tooling:

• Hardware & Infrastructure: Isolated UAT staging environments mirroring production capacity (95% hardware parity minimum).
• Software Access:
  • Enterprise Test Management Suite (e.g., Jira/Xray, Tricentis qTest, or Azure DevOps Test Plans).
  • Role-Based Access Control (RBAC) credentials assigned to all participating test profiles.
  • Version Control system access (GitHub Enterprise / GitLab) for traceability mapping.
• Certifications & Compliance: Designated Business Analysts and UAT Testers must hold internal Enterprise UAT Certification Level 2 or equivalent organizational validation credentials.
• Safety & Data Security PPE: Mandatory anonymization scripts executed on production data clones to ensure zero exposure of live PII in the UAT sandbox.

---

4. Roles & Responsibilities (RACI Matrix Table)

• Responsible (R): The operational role(s) that execute the activity.
• Accountable (A): The sole role with final approval and veto authority.
• Consulted (C): Subject matter experts providing critical inputs.
• Informed (I): Roles updated on progress and milestone completion.

---

5. Step-by-Step Operational Procedure

Phase 1: UAT Planning and Scope Baseline

• 1.1 Review and freeze the Business Requirements Document (BRD) and functional specifications with the Project Manager and Business Analysts.
• 1.2 Define the UAT boundary scope, identifying in-scope functional modules and explicit out-of-scope exclusions.
• 1.3 Establish the execution schedule, including resource allocations, daily stand-up windows, and critical milestone deadlines.
• 1.4 Validate that the UAT staging environment is provisioned with sanitized, anonymized datasets representative of production loads.

Phase 2: Test Scenario and Script Development

• 2.1 Translate approved BRD acceptance criteria into executable, step-by-step UAT test scripts using the enterprise test management platform.
• 2.2 Construct end-to-end (E2E) workflow scenarios covering core business operations, edge cases, and negative testing paths.
• 2.3 Establish expected result metrics and data verification points for every individual test step.
• 2.4 Conduct a peer review of all test scripts with business domain leads to ensure absolute alignment with operational workflows.

Phase 3: Test Execution & Defect Management

• 3.1 Conduct a UAT Kickoff Briefing with all Business Domain Testers to review test management tools, logging protocols, and triage expectations.
• 3.2 Execute test scripts sequentially, recording exact execution logs, timestamps, and pass/fail statuses.
• 3.3 Capture system output artifacts (screenshots, network logs, database states) for any executed step.
• 3.4 Log identified defects immediately into the tracking system with severity classifications (Critical, Major, Minor, Cosmetic) and reproduction steps.
• 3.5 Retest corrected defects upon notification of patch deployment by the development team (Regression Validation).

Phase 4: Sign-Off and Production Transition

• 4.1 Compile the final UAT Execution Summary Report, detailing total executed tests, pass rates, and unresolved variance justifications.
• 4.2 Convene the UAT Sign-Off Review Meeting with the Accountable parties (Project Manager and Business Owners).
• 4.3 Secure formal, digitized electronic signatures on the UAT Acceptance Certificate.
• 4.4 Authorize the deployment queue transition from the UAT staging environment to the production release pipeline.

---

6. Quality Assurance & Verification Criteria

To achieve formal validation sign-off, the testing cycle must satisfy the following strict quality thresholds:

• Execution Coverage Benchmark: 100% of high-priority (P1/P2) test scripts must be executed and explicitly marked as Passed. Medium/Low priority scripts may exhibit a maximum unexecuted tolerance of 2%, provided they do not impact core revenue operations.
• Defect Density Thresholds:
  • Critical Defects (Sev 1): 0 open defects permitted.
  • Major Defects (Sev 2): 0 open defects permitted without a formally documented, executive-approved operational workaround.
  • Minor/Cosmetic Defects (Sev 3/4): Maximum threshold of 5 non-blocking defects permitted, deferred to the post-implementation maintenance backlog.
• Audit Trail Compliance: 100% trace mapping between BRD requirements, UAT test scripts, and defect tracking logs.

---

7. Practical Troubleshooting Scenarios

Scenario A: Environment Data Corruption Mid-Cycle

• Trigger: Unexpected database purge or synchronization failure invalidates test datasets during active UAT execution, halting testing operations.
• Immediate Corrective Action Protocol:
  1. Halt all active UAT execution immediately and notify the UAT Coordinator and Technical Lead.
  2. Isolate the staging environment via access revocation to prevent further anomalous writes.
  3. Execute the automated data-restore script from the baseline golden snapshot established at the start of Phase 1.
  4. Perform data integrity validation checks to confirm baseline restoration.
  5. Issue an operational resumption notice to testing teams, logging the downtime event in the audit report.

Scenario B: High-Severity Defect Blocking Critical Path

• Trigger: A Severity 1 defect is discovered during core workflow testing, completely blocking an essential end-to-end business process.
• Immediate Corrective Action Protocol:
  1. The tester logs the defect with the classification "SEV-1 BLOCKER" and alerts the Development Lead and Project Manager instantly via priority paging.
  2. Development initiates an emergency hotfix triage within a 2-hour window.
  3. Pause testing on the affected module while allowing parallel testing on independent decoupled modules to continue if feasible.
  4. Once the hotfix patch is deployed to the staging environment, the QA lead re-runs the specific failed test script.
  5. Upon successful verification, resume normal E2E testing and document the incident duration in the final metrics report.